Detailseite
Projekt Druckansicht

Antivirale Aktivität von Guanylat-bindenden Proteinen und virale Gegenmaßnahmen

Fachliche Zuordnung Virologie
Förderung Förderung von 2018 bis 2022
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 400912104
 
Erstellungsjahr 2022

Zusammenfassung der Projektergebnisse

In the present project, we significantly advanced our understanding on the role of GBP proteins as antiviral restriction factors. We found that both GBP2 and GBP5 inhibit many viral pathogens by interfering with furin-mediated processing of their glycoproteins. We also obtained first evidence that GBP2 and GBP5 restrict SARS-CoV-2. In addition, we determined critical domains and structural requirements of their antiviral activity. Finally, we found that GBP2 and GBP5 are expressed under the control of endogenous retroviral RNAs and induced upon HIV-1 infection. Other results provide novel insights into the induction and inhibitory action of innate antiviral mechanisms. They also revealed that some innate antiviral effectors target cellular virus dependency factors rather than the virus directly. Finally, they identified an interesting example of how human cells might exploit endogenized retroviral LTR to produces antiviral factors upon infection with current viral pathogens. Altogether, we feel that the project yielded interesting results but also opened prospects for future studies.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung